Article Information
History
- May 23, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Benjamín Fernandez-Gutierrez1,
- Leticia Leon1,2,*,
- Alfredo Madrid1,
- Luis Rodriguez-Rodriguez1,
- Dalifer Freites1,
- Judit Font1,
- Arkaitz Mucientes1,
- Jose Ignacio Colomer1,
- Juan Angel Jover1,3 and
- Lydia Abasolo1
- 1Rheumatology Department and IDISSC, Hospital Clínico San Carlos, Madrid, Spain
- 2Universidad Camilo Jose Cela; Madrid, Spain
- 3Medicine Department. Universidad Complutense; Madrid, Spain
- ↵*Corresponding author: Leticia Leon
, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IDISSC), Hospital Clínico San Carlos; Madrid, Spain. Email: lleon{at}salud.madrid.org Tel/Fax.: +34-913303615/3414
Posted May 23, 2020.
Hospital admissions in inflammatory rheumatic diseases during the COVID-19 pandemic: incidence and role of disease modifying agents
